<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="122683">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01889472</url>
  </required_header>
  <id_info>
    <org_study_id>MNB-003</org_study_id>
    <secondary_id>JDBF-2012</secondary_id>
    <nct_id>NCT01889472</nct_id>
  </id_info>
  <brief_title>Impact of Interface With/Without Oral Appliance of Sleep Apnea Treatment</brief_title>
  <official_title>Impact of Nasal Mask/Oronasal Mask on Compliance to Treatment With Continuous Positive Airway Pressure (CPAP) in Patients With Obstructive Sleep Apnea</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laval University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laval University</source>
  <oversight_info>
    <authority>Canada: FRQS</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      CPAP is the most effective treatment of obstructive sleep apnea. Oro-nasal masks may be used
      in case of mouth leaks but these are associated with higher positive pressure needs and
      lower compliance to treatment. The present investigation evaluates if CPAP compliance would
      increase when an oral appliance is used in combination with a nasal mask compared to the use
      of an oro-nasal mask. Eligible patients are those demonstrating a low compliance when using
      an oro-nasal mask during CPAP therapy. Patients will be treated with automatic CPAP with one
      of the above-detailed interfaces for 4 weeks and data will be extracted from the machine
      report in each condition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participating subjects will be currently treated by CPAP and low compliance will be assessed
      according to machine report download demonstrating 3h or less of CPAP usage per night.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>CPAP compliance</measure>
    <time_frame>After 4 weeks of CPAP trial</time_frame>
    <safety_issue>No</safety_issue>
    <description>CPAP compliance will be assessed according to machine report download for the 4 weeks of treatment in each  study condition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>diurnal somnolence</measure>
    <time_frame>After 4 weeks of CPAP trial</time_frame>
    <safety_issue>No</safety_issue>
    <description>Epworth Sleepiness Score</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Respiratory disturbances index</measure>
    <time_frame>After 4 weeks of CPAP trial</time_frame>
    <safety_issue>No</safety_issue>
    <description>Provided by CPAP report</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">35</enrollment>
  <condition>Obstructive Sleep Apnea</condition>
  <arm_group>
    <arm_group_label>oro-nasal mask</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oro-nasal mask during 1 month of auto CPAP</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nasal mask and oral appliance</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nasal mask and oral appliance during 1 month of auto CPAP</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal mask and oral appliance vs oro-nasal mask during autoCPAP therapy</intervention_name>
    <arm_group_label>oro-nasal mask</arm_group_label>
    <arm_group_label>Nasal mask and oral appliance</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  normal nasal breathing

          -  dentition allowing for use of an oral appliance

          -  absence of mandibular joint pathology

        Exclusion Criteria:

          -  Clinical instability

          -  smoking cessation

          -  current weight loss strategy

          -  severe cardio-metabolic co-morbidity
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Frederic Series, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>IUCPQ</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Frederic Series, MD</last_name>
    <phone>418 656 8711</phone>
    <phone_ext>5513</phone_ext>
    <email>frederic.series@med.ulaval.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHUM</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Pierre Mayer, MD</last_name>
      <phone>514 890-8170</phone>
      <email>pierre.mayer@umontreal.ca</email>
    </contact>
    <investigator>
      <last_name>Pierre Mayer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IUCPQ</name>
      <address>
        <city>Quebec</city>
        <zip>G1V 4G5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Frederic Series, MD</last_name>
      <phone>418 656 8711</phone>
      <phone_ext>5513</phone_ext>
      <email>frederic.seriesd@med.ulaval.ca</email>
    </contact>
    <investigator>
      <last_name>Frederic Series, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>AGIRADOM</name>
      <address>
        <city>Grenoble</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JC Borel, PhD</last_name>
      <phone>04 76 51 03 04</phone>
      <email>j.borel@agiradom.com</email>
    </contact>
    <investigator>
      <last_name>JC Borel, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Borel JC, Tamisier R, Dias-Domingos S, Sapene M, Martin F, Stach B, Grillet Y, Muir JF, Levy P, Series F, Pepin JL; Scientific Council of The Sleep Registry of the French Federation of Pneumology (OSFP). Type of mask may impact on continuous positive airway pressure adherence in apneic patients. PLoS One. 2013 May 15;8(5):e64382. doi: 10.1371/journal.pone.0064382. Print 2013.</citation>
    <PMID>23691209</PMID>
  </reference>
  <verification_date>June 2013</verification_date>
  <lastchanged_date>June 26, 2013</lastchanged_date>
  <firstreceived_date>June 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Laval University</investigator_affiliation>
    <investigator_full_name>Frédéric Sériès</investigator_full_name>
    <investigator_title>Director IUCPQ sleep laboratory</investigator_title>
  </responsible_party>
  <keyword>CPAP compliance</keyword>
  <keyword>leaks</keyword>
  <keyword>Respiratory disturbances index</keyword>
  <keyword>quality of life</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
